Replies to post #82377 on Anavex Life Sciences Corp (AVXL)

[mapman1010]

that's what i am hoping as well.

Hopefully not everything will be up for bid and treatments like 2-73, whose safety profile far exceeds the current SOC, will benefit.

i am an original hippy, i was the first person in my middle school to wear pin striped bell bottoms, corduroy jacket and grow side burns. if i was born 5 years earlier i would have gone to Woodstock. i was the only student to get 100% on my final US History exam my junior year. i know history, politics and am well aware of current events. IMHO the times are a changin' and whether we like it or not Trump is the president-elect and i am going to try to see the glass half full.
I am sticking to my prediction that 2-73 or 3-71 will likely get approval 3qtr 2017. did anyone else notice that 3-71 appears to be ahead of 2-73 in Parkinson's according to the pipeline chart?